documents: FDA-2025-D-1504-0002
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| id | agency_id | docket_id | title | document_type | subtype | posted_date | posted_year | posted_month | comment_start_date | comment_end_date | last_modified | fr_doc_num | open_for_comment | withdrawn | object_id |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FDA-2025-D-1504-0002 | FDA | FDA-2025-D-1504 | Responding to FDA Form 483 Observations at the Conclusion of a Drug CGMP Inspection: Draft Guidance for Industry | Other | Guidance | 2026-03-09 | 2026 | 3 | 2026-03-09 | 2026-05-09 | 2026-04-10 09:00:26 | 1 | 0 | 09000064b9200f6d |